Anixa Biosciences Announces Notice of Allowance for Addition

/PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment and prevention of cancer and infectious...

Related Keywords

Eric Ribner , Jose Conejo Garcia , Anixa Biosciences , Alfredo Perales Puchalt , Amit Kumar , Mike Catelani , Anixa Bioscience , Lifesci Advisors , Drug Administration , Moffitt Cancer Center , Nasdaq , Prnewswire Anixa Biosciences Inc , Trademark Office , Anixa Biosciences Inc , Department Of Immunology At Moffitt Cancer Center , Certainty Therapeutics Inc , Wistar Institute , Chimeric Antigen Receptor T , Chimeric Endocrine Receptort Cell , Stimulating Hormone Receptor Mediated , Moffitt Cancer , Treating Cancer , Vice President , Certainty Therapeutics , Follicle Stimulating Hormone Receptor Mediated , Stimulating Hormone Receptor , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Sci Advisors , Nc ,